advancing innovation to save lives

President signs into law Global Health Innovation Act

President Trump signed into law in early January the Global Health Innovation Act,a bipartisan bill to support efforts by the US Agency for International Development to develop affordable, appropriate technologies to advance the health of people in the world's poorest places.
Learn More

GHTC releases brief analyzing WHO draft roadmap for access

Following the release of the World Health Organization's (WHO) final draft of its Road Map for Access to Medicines, Vaccines and Other Health Products, GHTC has published a new policy brief analyzing the contents of the road map and the potential implications, if approved.
View

Member Spotlight: GHIT Fund

GHIT Fund recently announced the appointment of Catherine Ohura as the organization’s new CEO and Executive Director. Learn more

Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 25 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more

PATH/Evelyn Hockstein
GHTC sends FY20 letters to House appropriators

GHTC sent letters to the relevant House appropriations subcommittees asking them to sustain and protect global health R&D funding in the fiscal year 2020 (FY20) budget.

Learn More

PATH/Lisa Mueller
GHTC joins alliance in urging G20 leaders to embrace global UHC commitments

GHTC helped author and endorsed a policy report from InterAction’s G7/G20 Advocacy Alliance urging G20 leaders to embrace global commitments to universal health coverage (UHC) by, among other methods, committing to robust public funding for R&D of new health technologies.

PDF
View All News & Events

Member Event

PATH/Jennifer Fox
The Essential Role of Diagnostics in Outbreak Detection and Response
AdvaMedDx, the American Society for Microbiology, the Association of Public Health Laboratories, and the Infectious Diseases Society of America
Learn More

Community Event

Flickr/United State Mission Geneva
72nd World Health Assembly
World Health Organization
Learn More
View All Events
PATH/Gabe Bienczycki
Research Roundup: AI advancing drug development, malaria vaccine tested in large clinical trial, and first-in-human universal flu vaccine trial

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Satvir Malhotra
Research Roundup: WHO emergency panel meets about Ebola in DRC, new study reveals HIV vulnerabilities, and how Global Health Investment Fund is revolutionizing impact investing

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide